These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6722254)

  • 1. Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1984 Mar; 5(2):89-93. PubMed ID: 6722254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1983 Oct; 4(4):294-8. PubMed ID: 6640057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interactions between antithrombin III, thrombin and surface immobilized heparin.
    van Delden CJ; Engbers GH; Feijen J
    J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity of antithrombin III for insoluble modified polystyrene.
    Boisson C; Gulino D; Jozefonvicz J
    Thromb Res; 1987 Apr; 46(1):101-8. PubMed ID: 3590108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin binding properties of insoluble modified polystyrene: Part II.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Boisson C; Gulino D; Jozefonvicz J
    Thromb Res; 1988 Apr; 50(2):317-24. PubMed ID: 3260695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1984 Mar; 5(2):94-9. PubMed ID: 6722255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-like tubings. II. Mechanism of the thrombin-antithrombin III reaction at the surface.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 May; 9(3):230-4. PubMed ID: 3408793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups.
    Boisson C; Jozefonvicz J; Brash JL
    Biomaterials; 1988 Jan; 9(1):47-52. PubMed ID: 3349121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption of plasma proteins onto anticoagulant polystyrene derivatives: a fluorescence study.
    Dulos E; Dufourcq J; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):405-12. PubMed ID: 3224125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of human platelets with insoluble anticoagulant modified polystyrene resins.
    Fougnot C; Lindon J; Kirshner L; Salzman EW; Jozefowicz M
    Biomaterials; 1984 May; 5(3):169-74. PubMed ID: 6733220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins.
    Fougnot C; Jozefowicz M; Bara L; Samama M
    Thromb Res; 1982 Oct; 28(1):37-46. PubMed ID: 7157229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
    Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition.
    Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D
    Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of thrombin-antithrombin III complex with vitronectin in serum.
    Ill CR; Ruoslahti E
    J Biol Chem; 1985 Dec; 260(29):15610-5. PubMed ID: 2415521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA; Salem HH
    Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.
    Lollar P; Owen WG
    J Clin Invest; 1980 Dec; 66(6):1222-30. PubMed ID: 6255009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of thrombins with human antithrombin III. I. Enzyme activity losses unrelated to the inhibitory reaction and their prevention.
    Latallo ZS; Hall JA
    Thromb Res; 1986 Sep; 43(5):507-21. PubMed ID: 3750277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):413-8. PubMed ID: 3224126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-like activity of insoluble sulphonated polystyrene resins. Part III: Binding of dicarboxylic amino acids.
    Douzon C; Kanmangne FM; Serne H; Labarre D; Jozefowicz M
    Biomaterials; 1987 May; 8(3):190-4. PubMed ID: 3607151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.